Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinitis pigmentosa that has material basis in variation in the chromosome region Xq28.
Data assembled from 2 of 12 sources · Last updated Nov 3, 2026, 2:37 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-curated news mentioning retinitis pigmentosa 34
Updated Oct 6, 2026
PYC Therapeutics anticipates significant clinical data for PYC-003, an RNA treatment targeting inherited polycystic kidney disease, which has investors excited as shares rose 5.1%. The company is also advancing therapies for retinitis pigmentosa type 11 and Phelan-McDermid syndrome, focusing on monogenic diseases with higher success rates in clinical trials.